Individual immune cell and cytokine profiles determine platelet-rich plasma composition

OBJECTIVE: Platelet-rich plasma (PRP) therapy is increasingly popular to treat musculoskeletal diseases, including tendinopathies and osteoarthritis (OA). To date, it remains unclear to which extent PRP compositions are determined by the immune cell and cytokine profile of individuals or by the prep...

Descripción completa

Detalles Bibliográficos
Autores principales: Niemann, Marcel, Ort, Melanie, Lauterbach, Luis, Streitz, Mathias, Wilhelm, Andreas, Grütz, Gerald, Fleckenstein, Florian N., Graef, Frank, Blankenstein, Antje, Reinke, Simon, Stöckle, Ulrich, Perka, Carsten, Duda, Georg N., Geißler, Sven, Winkler, Tobias, Maleitzke, Tazio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830842/
https://www.ncbi.nlm.nih.gov/pubmed/36627721
http://dx.doi.org/10.1186/s13075-022-02969-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830842/
https://www.ncbi.nlm.nih.gov/pubmed/36627721
http://dx.doi.org/10.1186/s13075-022-02969-6

Ejemplares similares